238 related articles for article (PubMed ID: 27626164)
1. Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma.
Qi Y; Xu F; Chen L; Li Y; Xu Z; Zhang Y; Wei W; Su N; Zhang T; Fan F; Wang X; Qin X; Zhang L; Liu Y; Xu P
Oncotarget; 2016 Oct; 7(42):68242-68252. PubMed ID: 27626164
[TBL] [Abstract][Full Text] [Related]
2. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
[TBL] [Abstract][Full Text] [Related]
3. Reveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomics.
Wang Y; Liu H; Liang D; Huang Y; Zeng Y; Xing X; Xia J; Lin M; Han X; Liao N; Liu X; Liu J
J Proteomics; 2017 Jan; 150():230-241. PubMed ID: 27693406
[TBL] [Abstract][Full Text] [Related]
4. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
5. Ectopic overexpression of filamin C scaffolds MEK1/2 and ERK1/2 to promote the progression of human hepatocellular carcinoma.
Yang B; Liu Y; Zhao J; Hei K; Zhuang H; Li Q; Wei W; Chen R; Zhang N; Li Y
Cancer Lett; 2017 Mar; 388():167-176. PubMed ID: 27919788
[TBL] [Abstract][Full Text] [Related]
6. KAP1 is overexpressed in hepatocellular carcinoma and its clinical significance.
Wang Y; Jiang J; Li Q; Ma H; Xu Z; Gao Y
Int J Clin Oncol; 2016 Oct; 21(5):927-933. PubMed ID: 27095111
[TBL] [Abstract][Full Text] [Related]
7. Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells.
Hu H; Ding X; Yang Y; Zhang H; Li H; Tong S; An X; Zhong Q; Liu X; Ma L; Liu Q; Liu B; Lu Z; Zhang D; Hu P; Ren H
Am J Physiol Gastrointest Liver Physiol; 2014 Sep; 307(6):G611-22. PubMed ID: 24994855
[TBL] [Abstract][Full Text] [Related]
8. [Research advances in application of isobaric tags for relative and absolute quantitation in proteomics of hepatocellular carcinoma].
Qi YZ; Chen LS; Xu P
Zhonghua Gan Zang Bing Za Zhi; 2016 Dec; 24(12):952-955. PubMed ID: 28073423
[TBL] [Abstract][Full Text] [Related]
9. The role of von Willebrand factor as a biomarker of tumor development in hepatitis B virus-associated human hepatocellular carcinoma: a quantitative proteomic based study.
Liu Y; Wang X; Li S; Hu H; Zhang D; Hu P; Yang Y; Ren H
J Proteomics; 2014 Jun; 106():99-112. PubMed ID: 24769235
[TBL] [Abstract][Full Text] [Related]
10. Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring.
Kim H; Kim K; Yu SJ; Jang ES; Yu J; Cho G; Yoon JH; Kim Y
PLoS One; 2013; 8(5):e63468. PubMed ID: 23717429
[TBL] [Abstract][Full Text] [Related]
11. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
[TBL] [Abstract][Full Text] [Related]
12. FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma.
Ai J; Huang H; Lv X; Tang Z; Chen M; Chen T; Duan W; Sun H; Li Q; Tan R; Liu Y; Duan J; Yang Y; Wei Y; Li Y; Zhou Q
Cell Physiol Biochem; 2011; 27(3-4):207-16. PubMed ID: 21471709
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
14. Identification of Protein Expression Changes in Hepatocellular Carcinoma through iTRAQ.
Zhang Y; Ying X; Zhao Q; Ma J; Zhang D; He C; Han S
Dis Markers; 2020; 2020():2632716. PubMed ID: 32076459
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of primary hepatocellular carcinoma with single and multiple lesions by iTRAQ-based quantitative proteomics.
Xing X; Huang Y; Wang S; Chi M; Zeng Y; Chen L; Li L; Zeng J; Lin M; Han X; Liu X; Liu J
J Proteomics; 2015 Oct; 128():262-71. PubMed ID: 26300425
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues.
Gao Y; Wang X; Sang Z; Li Z; Liu F; Mao J; Yan D; Zhao Y; Wang H; Li P; Ying X; Zhang X; He K; Wang H
Sci Rep; 2017 Apr; 7():45913. PubMed ID: 28378759
[TBL] [Abstract][Full Text] [Related]
17. Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma.
Xu X; Liu Z; Wang J; Xie H; Li J; Cao J; Zhou L; Zheng S
Oncotarget; 2016 Mar; 7(12):13730-41. PubMed ID: 26883192
[TBL] [Abstract][Full Text] [Related]
18. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
19. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of SLC5A8 inhibits hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling.
Hu BS; Xiong SM; Li G; Li JP
Tumour Biol; 2016 Oct; 37(10):13445-13453. PubMed ID: 27465549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]